Register information Patent

DE file number : 60 2015 079 989.5 (Status: pending/in force, Query started: April 28, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2015 079 989.5
96EP file numberEAKZ18 19 1446.6
97EP publication numberEPN3443983
54Designation/titleTIIMMUNOGENE GLYKOPROTEINKONJUGATE
51IPC main classICM
(ICMV)		 A61K 39/385 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 47/50 (2017.01), A61P 31/04 (2006.01)
22DE application dateDATFeb 6, 2015
96EP application dateEATFeb 6, 2015
43Date of first publicationOTFeb 20, 2019
Date of publication of grantPETJul 20, 2022
71/73Applicant/ownerINHPfizer Inc. (n.d.Ges.d.Staates Delaware), New York, NY, US
72InventorINGU, Jianxin, Paramus, NJ 07652, US; KAINTHAN, Rajesh Kumar, Tappan, NY 10983, US; KIM, Jin-Hwan, Suffern, NY 10901, US; PRASAD, Avvari Krishna, Chapel Hill, NC 27516, US; YANG, Yu-ying, Stamford, CT 06905, US
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201461939845 P
Feb 14, 2014
Due dateFT
FG		Feb 28, 2026
Annual fee for the 12th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003443983A1
Searchable text: EP000003443983A1
Original document: EP000003443983B1
Searchable text: EP000003443983B1
43Date of first publicationEVTFeb 20, 2019
Date of the first transfer into DPMAregisterEREGTFeb 20, 2019
Date of the (most recent) update in DPMAregisterREGTJan 18, 2025
(Show all update days)(Hide all update days)
  • Jan 18, 2025
    • Due date: changed
  • Jul 24, 2024
    • St.36: changed (technical change)
  • Jan 18, 2024; Jan 2, 2024; Dec 22, 2023; Jun 29, 2023; Jun 8, 2023; Jun 3, 2023; Oct 19, 2022; Oct 15, 2022; Aug 4, 2022; Jun 30, 2022; Aug 22, 2019
    • Historical data not available for this/these date(s)
  • Feb 20, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Feb 20, 2019  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Apr 4, 2019 Apr 4, 2019 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jul 20, 2022  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Aug 4, 2022 Aug 4, 2022 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Apr 21, 2023 Jul 20, 2023 Details anzeigen
6 New applicant/owner details New applicant/owner details Jun 2, 2023 Jul 13, 2023 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTFeb 20, 2019
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTApr 4, 2019
Issue numberHN14
YearPJ2019
Publication dateVTApr 4, 2019
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJul 20, 2022
Date of update of the procedureREGTJun 30, 2022
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTAug 4, 2022
Issue numberHN31
YearPJ2022
Publication dateVTAug 4, 2022
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTAug 4, 2022
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTApr 21, 2023
Issue numberHN29
YearPJ2023
Publication dateVTJul 20, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJun 29, 2023
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 2, 2023
Issue numberHN28
YearPJ2023
Publication dateVTJul 13, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHPfizer Inc. (n.d.Ges.d.Staates Delaware), New York, NY, US
71/73Previous applicant/ownerINHFPfizer Inc., New York, NY, US
Date of update of the procedureREGTJun 29, 2023